Therapy Areas: Autoimmune
RTW Biotech portfolio company Jade Biosciences merges with Aerovate Therapeutics
30 April 2025 - Investment company RTW Biotech Opportunities Ltd (LSE: RTW) on Wednesday announced the completion of a merger between its portfolio company Jade Biosciences and Aerovate Therapeutics. ...
Diamyd Medical to receive European patent for insulin antigen treatment targeting autoimmune diabetes
28 April 2025 - Swedish biotechnology company Diamyd Medical AB (Nasdaq First North Growth Market:DMYD-B) announced on Monday that the European Patent Office (EPO) has said it will grant Diamyd Medica...
Innovent's limertinib receives Chinese regulatory approval for first-line treatment of lung cancer
28 April 2025 - Innovent Biologics Inc (HKEX:01801), a China-based biopharmaceutical company that develops, manufactures and commercialises medicines for the treatment of oncologic, autoimmune, cardio...
InnoCare receives NMPA approval for orelabrutinib as first-line treatment for CLL/SLL in China
25 April 2025 - Biopharmaceutical company InnoCare Pharma (HKEX: 09969) (SSE: 688428) announced on Friday that the China National Medical Products Administration (NMPA) has approved its BTK inhibitor,...
Sanofi invests EUR15m in Innate Pharma to strengthen strategic partnership
24 April 2025 - Clinical-stage biotechnology company Innate Pharma SA (Euronext Paris:IPH) (Nasdaq:IPHA) on Thursday announced a capital increase of EUR14,999,998.59 through a strategic investment by ...
SynAct Pharma secures US patent allowance for resomelagon combination therapy in rheumatoid arthritis
23 April 2025 - Clinical stage biotechnology company SynAct Pharma AB (STO:SYNACT) announced on Wednesday that it has received a Notice of Allowance from the United States Patent and Trademark Office ...